Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease.

dc.contributor.author	Liyanage, I.K.
dc.contributor.author	Niriella, M.A.
dc.contributor.author	de Silva, A.P.
dc.contributor.author	de Silva, N.
dc.contributor.author	de Silva, H.J.
dc.date.accessioned	2019-10-26T07:06:12Z
dc.date.available	2019-10-26T07:06:12Z
dc.date.issued	2019
dc.identifier.citation	ACG Case Reports Journal.2019;6(6):e00075	en_US
dc.identifier.issn	2326-3253 (Electronic)
dc.identifier.uri	http://repository.kln.ac.lk/handle/123456789/20449
dc.description	Not indexed in MEDLINE. ESCI	en_US
dc.description.abstract	Tumor necrosis factor-α inhibitor (TNF-α) is frequently used for Crohn's disease and other autoimmune conditions. Increased risk of infection is an accepted adverse effect of TNF-α, and routine screening for potential infections are carried out before initiation of therapy. We report the case of a patient who developed a localized painful swelling near the injection site, which was diagnosed as acute dermato-lymphangio-adenitis due to filarial infection. This adds to the limited number of case reports on parasitic complications following TNF-α therapy	en_US
dc.language.iso	en	en_US
dc.publisher	American College of Gastroenterology	en_US
dc.subject	Crohn's disease	en_US
dc.title	Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease.	en_US
dc.type	Article	en_US

Files in this item

Name: crohn's disease.pdf

Size: 438.1Kb

Format: PDF

Journal/Magazine Articles
Articles published in local and international journals by the Staff of the Faculty of Medicine